Clinical Trials Logo
  1. Home
  2. Pleural Effusion, Malignant
  3. NCT03394105

Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer

Pleural Effusion, Malignant Clinical Trial

Official title:
Pilot Study to Evaluate the Effect of Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer

Clinical Trial Summary

In this trial, the effect of intrapleural docetaxel administration using medical pleuroscopywill be evaluated in Lung Cancer patient with malignant effusion.

Clinical Trial Description

This study is designed to be pilot, single-center, open-label, single-arm, prospective, phase II trial of patient with NSCLC with pleurla effusion. Approximately 40 patients will be enrolled into the trial, and study will be performed to 31Dec2018 from IRB and Korea: MFDS approval date.

Docetaxel will be administed to interpleural space using medical pleuroscopy in malignant effusion with lung cancer. Response evaluation will be done until confiramtion of disease progression. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03394105
Study type Interventional
Source Asan Medical Center
Contact
Status Completed
Phase Phase 2
Start date July 26, 2016
Completion date June 22, 2018
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05693727 - Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate Dehydrogenase, interferonY, Tumor Necrosis Factor,and Interleukins{2,12,18}for Differentiation Between Malignant and Non Malignant Pleural Effusion
Recruiting NCT05910112 - Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention
Completed NCT03270215 - The Added Value of CT Scanning in Patients With an Unilateral Pleural Effusion
Completed NCT03272997 - The Value of PET-CT in Pleural Effusions
Completed NCT00099541 - Non-small Cell Lung Cancer Registry Phase 4
Recruiting NCT04844827 - Pleural Carcinomatosis Tissue Banking
Recruiting NCT05278975 - Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma Phase 1/Phase 2
Recruiting NCT02407912 - Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer N/A
Terminated NCT00316134 - Multiple Biomarkers in Undiagnosed Pleural Effusion N/A
Not yet recruiting NCT06275178 - Medical Thoracoscopy for Diagnosing Unexplained Pleural Effusion: a National Multicenter Retrospective Study
Recruiting NCT04684459 - Dual-targeting HER2 and PD-L1 CAR-T for Cancers With Pleural or Peritoneal Metastasis Early Phase 1
Recruiting NCT04670562 - Longitudinal Follow up of Patients With Pleural Effusion
Not yet recruiting NCT02805062 - Manometry vs Clinical Assessment in the Detection of Trapped Lung in Patients With Suspected Pleural Malignancy N/A
Completed NCT03276715 - Prognostic Factors on Malignant Pleural Effusion
Recruiting NCT05461430 - Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
Terminated NCT02702700 - Photo-induction as a Means to Improve Cisplatin Delivery to Pleural Malignancies Phase 1
Recruiting NCT02045121 - Multicentre Study Comparing Indwelling Pleural Catheter With Talc Pleurodesis for Malignant Pleural Effusion Management N/A
Completed NCT01670786 - Safety Profile of Iodopovidone as an Agent for Pleurodesis in Malignant Pleural Effusion Phase 4
Active, not recruiting NCT05077111 - A Comparative Study Between Regional Anesthesia in Thoracoscopes and the Conventional General Anesthesia Phase 4
Not yet recruiting NCT03781908 - Management of Malignant Pleural Effusion With Indwelling Pleural Catheter Versus Silver Nitrate Pleurodesis Phase 1/Phase 2